Cite
Li X, Kitpanit S, Lee A, et al. Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy. JAMA Netw Open. 2021;4(6):e2113205doi: 10.1001/jamanetworkopen.2021.13205.
Li, X., Kitpanit, S., Lee, A., Mah, D., Sine, K., Sherman, E. J., Dunn, L. A., Michel, L. S., Fetten, J., Zakeri, K., Yu, Y., Chen, L., Kang, J. J., Gelblum, D. Y., McBride, S. M., Tsai, C. J., Riaz, N., & Lee, N. Y. (2021). Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy. JAMA network open, 4(6), e2113205. https://doi.org/10.1001/jamanetworkopen.2021.13205
Li, Xingzhe, et al. "Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy." JAMA network open vol. 4,6 (2021): e2113205. doi: https://doi.org/10.1001/jamanetworkopen.2021.13205
Li X, Kitpanit S, Lee A, Mah D, Sine K, Sherman EJ, Dunn LA, Michel LS, Fetten J, Zakeri K, Yu Y, Chen L, Kang JJ, Gelblum DY, McBride SM, Tsai CJ, Riaz N, Lee NY. Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy. JAMA Netw Open. 2021 Jun 01;4(6):e2113205. doi: 10.1001/jamanetworkopen.2021.13205. PMID: 34143193; PMCID: PMC8214161.
Copy
Download .nbib